NO164895C - Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.

Info

Publication number
NO164895C
NO164895C NO864101A NO864101A NO164895C NO 164895 C NO164895 C NO 164895C NO 864101 A NO864101 A NO 864101A NO 864101 A NO864101 A NO 864101A NO 164895 C NO164895 C NO 164895C
Authority
NO
Norway
Prior art keywords
dichloranilin
derivatives
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO864101A
Other languages
English (en)
Norwegian (no)
Other versions
NO864101D0 (no
NO864101L (no
NO164895B (no
Inventor
Ian Frederick Skidmore
Lawrence Henry Charles Lunts
Harry Finch
Alan Naylor
Ian Baxter Campbell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO864101D0 publication Critical patent/NO864101D0/no
Publication of NO864101L publication Critical patent/NO864101L/no
Publication of NO164895B publication Critical patent/NO164895B/no
Publication of NO164895C publication Critical patent/NO164895C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/45Monoamines
    • C07C211/46Aniline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO864101A 1985-10-15 1986-10-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. NO164895C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858525321A GB8525321D0 (en) 1985-10-15 1985-10-15 Chemical compounds

Publications (4)

Publication Number Publication Date
NO864101D0 NO864101D0 (no) 1986-10-14
NO864101L NO864101L (no) 1987-04-21
NO164895B NO164895B (no) 1990-08-20
NO164895C true NO164895C (no) 1990-11-28

Family

ID=10586651

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864101A NO164895C (no) 1985-10-15 1986-10-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.

Country Status (21)

Country Link
JP (1) JPS62149651A (fi)
KR (1) KR870003970A (fi)
AT (1) AT395972B (fi)
AU (1) AU591188B2 (fi)
BE (1) BE905601A (fi)
CA (1) CA1296335C (fi)
CH (1) CH669787A5 (fi)
DE (1) DE3634974A1 (fi)
DK (1) DK491786A (fi)
ES (1) ES2002036A6 (fi)
FI (1) FI89164C (fi)
FR (1) FR2591590B1 (fi)
GB (2) GB8525321D0 (fi)
IE (1) IE59466B1 (fi)
IL (2) IL78432A (fi)
IT (1) IT1205360B (fi)
NL (1) NL8602575A (fi)
NO (1) NO164895C (fi)
PT (1) PT83531B (fi)
SE (1) SE467541B (fi)
ZA (1) ZA867772B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU581887B2 (en) * 1984-04-17 1989-03-09 Glaxo Group Limited Ethanolamine compounds
GB8718938D0 (en) * 1987-08-11 1987-09-16 Glaxo Group Ltd Chemical compounds
GB8718939D0 (en) * 1987-08-11 1987-09-16 Glaxo Group Ltd Chemical compounds
US5149698A (en) * 1987-08-11 1992-09-22 Glaxo Group Limited Chloroaniline derivatives
ES2039646T3 (es) * 1987-11-13 1993-10-01 Glaxo Group Limited Derivados de fenetanolamina.
ZA889405B (en) * 1987-12-18 1989-12-27 Glaxo Group Ltd Ethanolamine derivatives
NZ227365A (en) * 1987-12-18 1990-10-26 Glaxo Group Ltd Aromatic amino ethers and pharmaceutical compositions
GB8808892D0 (en) * 1988-04-15 1988-05-18 British Bio Technology Gene synthesis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1618005A1 (de) * 1966-09-22 1971-09-09 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen
DE2351281C3 (de) * 1973-10-12 1981-07-30 Dr. Karl Thomae Gmbh, 7950 Biberach Aminophenyl-äthanolamin-Derivate, deren Herstellung und Verwendung
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
AU581887B2 (en) * 1984-04-17 1989-03-09 Glaxo Group Limited Ethanolamine compounds
GB8426191D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds

Also Published As

Publication number Publication date
CA1296335C (en) 1992-02-25
FI89164B (fi) 1993-05-14
GB8525321D0 (en) 1985-11-20
AT395972B (de) 1993-04-26
NO864101D0 (no) 1986-10-14
BE905601A (fr) 1987-04-15
IL78432A (en) 1990-09-17
CH669787A5 (fi) 1989-04-14
AU591188B2 (en) 1989-11-30
KR870003970A (ko) 1987-05-06
PT83531B (pt) 1989-05-31
SE467541B (sv) 1992-08-03
FI864137A (fi) 1987-04-16
IL80294A (en) 1990-11-29
NO864101L (no) 1987-04-21
GB2182658B (en) 1990-01-31
FI89164C (fi) 1993-08-25
IT1205360B (it) 1989-03-15
JPS62149651A (ja) 1987-07-03
DE3634974A1 (de) 1987-05-27
GB8624630D0 (en) 1986-11-19
DK491786D0 (da) 1986-10-14
SE8604349L (sv) 1987-04-16
IE862707L (en) 1987-04-15
IE59466B1 (en) 1994-02-23
NO164895B (no) 1990-08-20
PT83531A (en) 1986-11-01
FR2591590B1 (fr) 1990-05-11
ES2002036A6 (es) 1988-07-01
SE8604349D0 (sv) 1986-10-14
DK491786A (da) 1987-04-16
FR2591590A1 (fr) 1987-06-19
NL8602575A (nl) 1987-05-04
AU6395986A (en) 1987-04-16
FI864137A0 (fi) 1986-10-14
GB2182658A (en) 1987-05-20
ZA867772B (en) 1988-07-27
ATA273486A (de) 1992-09-15
IT8648547A0 (it) 1986-10-14

Similar Documents

Publication Publication Date Title
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO167384C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-aralkylpiperidinmethanolderivater.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO162514C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinonderivater.
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO165023C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol- og furan derivater.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO862956D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO167026C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO891114D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO164895C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.